IP Library › Granted Patent US 8,026,242
Granted Patent B2
US 8,026,242 · App. 13/028,351 · Granted Sep 27, 2011

Cyclopropyl amines as modulators of the histamine H

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,026,242
App. No.
13/028,351
Granted
Sep 27, 2011
Kind
B2
Abstract

Certain cyclopropyl amines are histamine H 3 modulators useful in the treatment of histamine H 3 receptor mediated diseases.

Claims (5)

1. A compound that is (4-cyclopropyl-piperazin-1-yl)-[4-(4-fluoro-piperidin-1-ylmethyl)-phenyl]-methanone, or enantiomers or pharmaceutically acceptable salts thereof.

2. A compound of claim 1 that is (4-cyclopropyl-piperazin-1-yl)-[4-(4-fluoro-piperidin-1-ylmethyl)-phenyl]-methanone or a pharmaceutically acceptable salt thereof.

3. A compound that is (4-cyclopropyl-piperazin-1-yl)-[4-(4-fluoro-piperidin-1-ylmethyl)-phenyl]-methanone citrate salt.

4. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an effective amount of (4-cyclopropyl-piperazin-1-yl)-[4-(4-fluoro-piperidin-1-ylmethyl)-phenyl]-methanone, or enantiomers or pharmaceutically acceptable salts thereof.

5. A pharmaceutical composition according to claim 4 , further comprising topiramate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2011
From: ALLISON, BRETT D.; CARRUTHERS, NICHOLAS I.; GRICE, CHERYL A.; LETAVIC, MICHAEL A.
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 025816/0368 →
Continuity (3)
Division 11531849 · Sep 14, 2006
Provisional Application 60717659 · Sep 16, 2005
Related Publication 20110136797A1 · Jun 9, 2011